Prevalence and correlates of 25-hydroxyvitamin D deficiency in the Chronic Kidney Disease in Children (CKiD) cohort

Pediatr Nephrol. 2016 Jan;31(1):121-9. doi: 10.1007/s00467-015-3190-7. Epub 2015 Aug 26.

Abstract

Background: Vitamin D plays an important role in the mineral and bone disorder seen in chronic kidney disease (CKD). Deficiency of 25-hydroxyvitamin D (25OHD) is highly prevalent in the adult CKD population.

Methods: The prevalence and determinants of 25OHD deficiency (defined as a level <20 ng/ml) were examined longitudinally in 506 children in the CKiD cohort. Predictors of secondary hyperparathyroidism and the determinants of 1,25-dihydroxyvitamin D (1,25(OH)2D) levels were also evaluated.

Results: Deficiency of 25OHD was observed in 28 % of the cohort at enrollment. Significant predictors of 25OHD deficiency were older age, non-white race, higher body mass index, assessment during winter, less often than daily milk intake, non-use of nutritional vitamin D supplement and proteinuria. Lower values of glomerular filtration rate (GFR), serum 25OHD, calcium and higher levels of FGF23 were significant determinants of secondary hyperparathyroidism. Lower GFR, low serum 25OHD, nephrotic-range proteinuria, and high FGF23 levels were significant determinants of serum 1,25(OH)2 D levels.

Conclusions: Deficiency of 25OHD is prevalent in children with CKD and is associated with potentially modifiable risk factors such as milk intake, nutritional vitamin D supplement use, and proteinuria. 25OHD deficiency is a risk factor for secondary hyperparathyroidism and decreased serum 1,25(OH)2D in children with CKD.

Keywords: Chronic renal disease; Fibroblast growth factor 23; Hyperparathyroidism; Mineral metabolism; Pediatric.

Publication types

  • Multicenter Study
  • Research Support, N.I.H., Extramural

MeSH terms

  • Adolescent
  • Age Factors
  • Animals
  • Biomarkers / blood
  • Body Mass Index
  • Child
  • Child, Preschool
  • Dietary Supplements
  • Female
  • Fibroblast Growth Factor-23
  • Humans
  • Hyperparathyroidism, Secondary / blood
  • Hyperparathyroidism, Secondary / diagnosis
  • Hyperparathyroidism, Secondary / epidemiology
  • Infant
  • Longitudinal Studies
  • Male
  • Milk
  • North America / epidemiology
  • Nutritional Status
  • Parathyroid Hormone / blood
  • Prevalence
  • Prognosis
  • Prospective Studies
  • Renal Insufficiency, Chronic / diagnosis
  • Renal Insufficiency, Chronic / epidemiology*
  • Renal Insufficiency, Chronic / therapy
  • Risk Assessment
  • Risk Factors
  • Seasons
  • Time Factors
  • Vitamin D / analogs & derivatives*
  • Vitamin D / blood
  • Vitamin D Deficiency / blood
  • Vitamin D Deficiency / diagnosis
  • Vitamin D Deficiency / epidemiology*
  • Vitamin D Deficiency / therapy

Substances

  • Biomarkers
  • FGF23 protein, human
  • PTH protein, human
  • Parathyroid Hormone
  • Vitamin D
  • Fibroblast Growth Factor-23
  • 25-hydroxyvitamin D